Analyst firms · Rosenblatt · CME

Rosenblatt CME price target and rating history

CME Group Inc. (CME) · Finance

Rosenblatt rates CME Group Inc. (CME) Sell with a $171 price target, as of its latest action on Aug 17, 2022. It has published 4 rating actions on CME since October 2021, including 1 upgrade and 0 downgrades. Across 5 firms with a CME price target in the last 12 months, the median target is $305.

Current rating

Sell

Price target

$171

Median target, all firms

$305

Actions on CME

4

Rosenblatt price target on CME

Every Rosenblatt rating on CME

• Aug 17, 2022
  InitiateRosenblatt starts coverage at Sell, price target $171
• Mar 8, 2022
  ReiterateRosenblatt raises its price target to $268 from $260, keeps Neutral
• Jan 20, 2022
  UpgradeRosenblatt upgrades to Neutral from Sell, price target $254
• Oct 28, 2021
  ReiterateRosenblatt raises its price target to $197 from $194, keeps Sell

How other firms rate CME

Each firm's latest rating and stated target in the last 12 months.

Questions about Rosenblatt and CME

What is Rosenblatt's price target for CME?

Rosenblatt's latest stated price target for CME Group Inc. (CME) is $171, from its action on Aug 17, 2022.

What is Rosenblatt's rating on CME?

Rosenblatt rates CME Sell, a bearish rating, as of Aug 17, 2022.

When did Rosenblatt last change its view on CME?

On Aug 17, 2022, Rosenblatt starts coverage at Sell, price target $171.

How does Rosenblatt's CME target compare with other analysts?

Across 5 firms with a CME price target in the last 12 months, the median target is $305.

More CME rating histories

• Deutsche Bank4
• Citigroup4
• Morgan Stanley5
• Raymond James5
• BofA Securities4
• Credit Suisse4
• Atlantic Equities4

All Rosenblatt ratingsCME news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.